Old Web
English
Sign In
Acemap
>
authorDetail
>
Ricardo Maamari
Ricardo Maamari
Novartis
Pasireotide
Internal medicine
Endocrinology
Medicine
Cushing's disease
6
Papers
25
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Evaluation of the Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Inadequately Controlled With First-Generation Somatostatin Analogs
2020
Frontiers in Endocrinology
Mônica R. Gadelha
Marie Bex
Annamaria Colao
Elier Mitsael Pedroza-García
Catalina Poiana
Marisela Jiménez Sánchez
Serkan Yener
Rishav Mukherjee
Amy Bartalotta
Ricardo Maamari
Gerald Raverot
Show All
Source
Cite
Save
Citations (7)
MON-445 Long-Term Results of an Ongoing Non-Interventional, Real-World Observational Study of Pasireotide SC in Cushing's Disease
2019
Journal of the Endocrine Society
Kevin C. J. Yuen
Carla Giordano
Timo Deutschbein
Luca Manetti
Michael Roughton
Ulrike Kriemler-Krahn
Libuse Tauchmanova
Ricardo Maamari
Jochen Schopohl
Show All
Source
Cite
Save
Citations (0)
Association between biochemical control and comorbidities in patients with acromegaly: an Italian longitudinal retrospective chart review study
2019
Journal of Endocrinological Investigation
A. Colao
Ludovica F. S. Grasso
M Di Cera
Philippe Thompson-Leduc
Wendy Y. Cheng
Hoi Ching Cheung
Mei Sheng Duh
Maureen P. Neary
Alberto M Pedroncelli
Ricardo Maamari
Rosario Pivonello
Show All
Source
Cite
Save
Citations (9)
Safety and efficacy of subcutaneous pasireotide in patients with Cushing’s disease: Results from an open-label, multicenter, single-arm, multinational, expanded-access study
2019
Frontiers in Endocrinology
Maria Fleseriu
Chioma Iweha
Luiz Roberto Salgado
Tânia Longo Mazzuco
Federico Campigotto
Ricardo Maamari
Padiporn Limumpornpetch
Show All
Source
Cite
Save
Citations (5)
1